4.23

3.20% -0.14

Iovance Biotherapeutics Inc (IOVA)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Financials Perché IOVA Giù? Forum Previsione Frazionamento azionario

Precedente Chiudi:

$4.37

Aprire:

$4.41

Volume 24 ore:

9.92M

Relative Volume:

0.66

Capitalizzazione di mercato:

$1.89B

Reddito:

$285.55M

Utile/perdita netta:

$-353.86M

Rapporto P/E:

-4.4522

EPS:

-0.9501

Flusso di cassa netto:

$-305.02M

1 W Prestazione:

-1.86%

1M Prestazione:

+11.90%

6M Prestazione:

+72.65%

1 anno Prestazione:

+119.17%

Intervallo 1D:

$4.145

$4.45

Intervallo di 1 settimana:

$4.07

$4.5399

Portata 52W:

$1.70

$5.63

Iovance Biotherapeutics Inc Stock (IOVA) Company Profile

Nome

Iovance Biotherapeutics Inc

Settore

Healthcare (1096)

Industria

Biotechnology (616)

Telefono

(650) 260-7120

Indirizzo

825 INDUSTRIAL ROAD, SAN CARLOS

Dipendente

975

Cinguettio

Prossima data di guadagno

2026-08-06

Ultimi documenti SEC

IOVA's Discussions on Twitter

Compare IOVA vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
IOVA Iovance Biotherapeutics Inc	4.23	1.89B	285.55M	-353.86M	-305.02M	-0.9501
VRTX Vertex Pharmaceuticals Inc	485.39	123.19B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	664.52	69.67B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	877.62	54.58B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	298.76	39.89B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	186.88	39.73B	742.00K	-1.37B	-1.07B	-7.0731

Iovance Biotherapeutics Inc Stock (IOVA) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2026-02-25	Aggiornamento	Citizens	Mkt Perform → Mkt Outperform
2025-07-15	Downgrade	Goldman	Neutral → Sell
2025-05-16	Downgrade	UBS	Buy → Neutral
2025-05-12	Downgrade	Truist	Buy → Hold
2025-05-09	Downgrade	Citizens JMP	Mkt Outperform → Mkt Perform
2024-10-24	Iniziato	UBS	Buy
2024-07-29	Downgrade	Piper Sandler	Overweight → Neutral
2023-11-20	Iniziato	Goldman	Buy
2023-09-18	Reiterato	Barclays	Overweight
2023-05-30	Aggiornamento	Wells Fargo	Equal Weight → Overweight
2023-03-27	Ripresa	Wells Fargo	Equal Weight
2023-01-27	Aggiornamento	Piper Sandler	Neutral → Overweight
2022-12-09	Downgrade	Goldman	Buy → Neutral
2022-10-31	Iniziato	Guggenheim	Neutral
2022-08-18	Ripresa	Wells Fargo	Equal Weight
2022-01-28	Aggiornamento	Stifel	Hold → Buy
2021-12-07	Ripresa	Cowen	Outperform
2021-06-10	Aggiornamento	JMP Securities	Mkt Perform → Mkt Outperform
2021-05-20	Downgrade	Piper Sandler	Overweight → Neutral
2021-05-19	Downgrade	JMP Securities	Mkt Outperform → Mkt Perform
2021-05-19	Downgrade	Stifel	Buy → Hold
2021-05-03	Iniziato	Truist	Buy
2021-04-16	Iniziato	Goldman	Buy
2021-03-08	Aggiornamento	H.C. Wainwright	Neutral → Buy
2020-12-15	Downgrade	H.C. Wainwright	Buy → Neutral
2020-10-06	Downgrade	Wells Fargo	Overweight → Equal Weight
2020-04-22	Iniziato	Mizuho	Buy
2020-03-04	Iniziato	Barclays	Overweight
2020-02-26	Reiterato	H.C. Wainwright	Buy
2020-02-26	Reiterato	Oppenheimer	Outperform
2019-12-18	Iniziato	JMP Securities	Mkt Outperform
2019-10-01	Iniziato	Stifel	Buy
2019-04-29	Iniziato	Piper Jaffray	Overweight
2019-02-28	Reiterato	Chardan Capital Markets	Buy
2019-02-07	Iniziato	Robert W. Baird	Outperform
2018-12-31	Ripresa	B. Riley FBR	Buy
2018-07-06	Reiterato	Chardan Capital Markets	Buy
2018-04-10	Aggiornamento	B. Riley FBR, Inc.	Neutral → Buy
2018-03-13	Reiterato	B. Riley FBR, Inc.	Neutral
2018-02-23	Downgrade	B. Riley FBR, Inc.	Buy → Neutral
2018-01-25	Reiterato	H.C. Wainwright	Buy
2017-11-01	Reiterato	B. Riley FBR, Inc.	Buy

Mostra tutto

Iovance Biotherapeutics Inc Borsa (IOVA) Ultime notizie

Jul 10, 2026

Why Is IOVA Stock Falling Today? - Stocktwits

Jul 10, 2026

Jul 09, 2026

After IOVA Stock’s Best Day In 2 Years, Analyst Sees Over 300% Upside: Here’s Why - Stocktwits

Jul 09, 2026

Iovance Biotherapeutics (IOVA) Updates its Corporate Presentation, Here’s What’s Important to Note - Insider Monkey

Jul 09, 2026

IOVA Stock Slump Takes Wall Street, Retail By Surprise — Here’s Why - Stocktwits

Jul 09, 2026

Jul 08, 2026

Heartflow vs. Iovance Biotherapeutics: Which Healthcare Stock Is a Better Buy in 2026? - AOL.com

Jul 08, 2026

This Stock Is Up 74% This Year: Is It Too Late to Buy? - The Motley Fool

Jul 08, 2026

Jul 07, 2026

Enterprise value to revenue forward of Iovance Biotherapeutics, Inc. – NASDAQ:IOVA - TradingView

Jul 07, 2026

Jul 06, 2026

symbol__ Stock Quote Price and Forecast - CNN

Jul 06, 2026

Jul 05, 2026

IOVAIovance Biotherapeutics Inc Options - Finviz

Jul 05, 2026

Jul 02, 2026

Iovance Biotherapeutics updates corporate presentation, reiterates $350M–$370M FY26 guidance - TradingView

Jul 02, 2026

Iovance Biotherapeutics (IOVA) projects 2026 revenue of $350M–$370M and cash runway into 2028 - Stock Titan

Jul 02, 2026

IOVA Stock Price, Quote & Chart - ChartMill

Jul 02, 2026

Jun 30, 2026

IBRX Vs IOVA: Which Cancer Immunotherapy Stock Has Bigger Breakout Ahead? - Stocktwits

Jun 30, 2026

Jun 29, 2026

IOVA News | IOVANCE BIOTHERAPEUTICS INC (NASDAQ:IOVA) - ChartMill

Jun 29, 2026

IOVANCE BIOTHERAPEUTICS INC (NASDAQ:IOVA) Passes Mark Minervini’s Trend Template and High-Growth Momentum Screen - ChartMill

Jun 29, 2026

Jun 28, 2026

Iovance Biotherapeutics Inc Annual Shareholders Meeting Transcript - GuruFocus

Jun 28, 2026

REPL Vs IOVA: FDA Decision Day Could Test Biotech Bulls’ Conviction On These Melanoma Plays - Stocktwits

Jun 28, 2026

Jun 27, 2026

Enterprise value to revenue forward of Iovance Biotherapeutics Inc – SWB:2LB - TradingView

Jun 27, 2026

Lost Money on Iovance Biotherapeutics, Inc. (IOVA)? Urged to Join - The National Law Review

Jun 27, 2026

Why Iovance Biotherapeutics (IOVA) Is Up 7.7% After Australian Conditional OK For Amtagvi Cell Therapy - Sahm

Jun 27, 2026